Pfizer has won the bidding war against Novo Nordisk to acquire obesity-drug biotech Metsera. The pharma giant upped its offer ...
NEW YORK/LONDON (Reuters) -A bidding war over U.S. biotech Metsera was coming to a head on Thursday, with Danish drugmaker ...
People taking GLP-1 meds could see costs drop in 2026, thanks to a new federal deal with Eli Lilly and Novo Nordisk, the ...
"Trump's meltdown unfolds as a fiery clapback rattles him to the core, leading to a desperate attempt to salvage his dignity, only to ...
Experts say the deal to lower the cost of the drugs is ambitious, but left some with more questions than answers.
A viral video circulated online in November 2025 that purported to show the United States Secretary of the Department of ...
As the executives took turns congratulating themselves, Findlay, who was standing in the back, began to wobble. David Ricks, ...
The deal announced on Thursday, covering Novo's Wegovy and Lilly's Zepbound, will reduce monthly prices for U.S. government ...
The Centers for Medicare & Medicaid Services is launching a new initiative for state Medicaid programs to purchase prescription drugs at prices aligned with those paid in other countries, known as ...
10hon MSN
Millions more Americans could access obesity drugs after Trump's deals with Eli Lilly, Novo Nordisk
Medicare will start covering obesity drugs for the first time, which could open access to millions of seniors and spur more ...
A viral Oval Office incident showing RFK Jr. appearing to “flee” after a man collapsed during Trump’s press conference sparks online debate, prompting White House clarification that he left to get ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results